CII
ALNY icon

Capital International Inc’s Alnylam Pharmaceuticals ALNY Stock Holding History

Capital International Inc’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.73M Buy
25,671
+121
+0.5% +$36.5K 0.05% 213
2026
Q1 		$8.45M Sell
25,550
-34,002
-57% -$11.6M 0.07% 203
2025
Q4 		$23.7M Sell
59,552
-16,086
-21% -$7.12M 0.19% 142
2025
Q3 		$34.5M Buy
75,638
+3,807
+5% +$1.55M 0.28% 95
2025
Q2 		$23.4M Buy
71,831
+4,870
+7% +$1.35M 0.23% 118
2025
Q1 		$18.1M Sell
66,961
-38,124
-36% -$9.8M 0.22% 125
2024
Q4 		$24.7M Sell
105,085
-20,136
-16% -$5.3M 0.29% 98
2024
Q3 		$34.4M Buy
125,221
+11,237
+10% +$2.93M 0.43% 65
2024
Q2 		$27.7M Buy
113,984
+20,608
+22% +$3.25M 0.37% 77
2024
Q1 		$14M Sell
93,376
-6,646
-7% -$1.11M 0.19% 139
2023
Q4 		$19.1M Buy
100,022
+3,549
+4% +$605K 0.3% 103
2023
Q3 		$17.1M Buy
96,473
+38,626
+67% +$7.37M 0.33% 93
2023
Q2 		$11M Buy
57,847
+6,555
+13% +$1.3M 0.2% 137
2023
Q1 		$10.3M Buy
51,292
+4,082
+9% +$858K 0.21% 125
2022
Q4 		$11.2M Buy
47,210
+8,148
+21% +$1.74M 0.24% 118
2022
Q3 		$7.82M Sell
39,062
-3,101
-7% -$591K 0.17% 134
2022
Q2 		$6.15M Buy
42,163
+22,773
+117% +$3.23M 0.09% 170
2022
Q1 		$3.17M Buy
+19,390
New +$2.95M 0.04% 205

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Inc's ALNY Position: Q2 2026 in Review

Capital International Inc increased its Alnylam Pharmaceuticals (ALNY) stake by 0.47% in Q2 2026, buying an estimated $36.5K and bringing the position to 25,671 shares worth $7.73M. The position accounts for 0.05% of the portfolio, ranked #213.

Capital International Inc first reported a position in ALNY in Q1 2022 and has held it in 18 quarters since. The position peaked at $34.5M in Q3 2025. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Capital International Inc held 25,671 shares of Alnylam Pharmaceuticals worth $7.73M as of Q2 2026.
  • Capital International Inc bought 121 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $36.5K.
  • Alnylam Pharmaceuticals made up 0.05% of Capital International Inc's portfolio in Q2 2026, its #213 holding.
  • Capital International Inc first reported a position in Alnylam Pharmaceuticals in Q1 2022 and has held it in 18 quarters since.
  • Capital International Inc's Alnylam Pharmaceuticals position peaked at $34.5M in Q3 2025.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Capital International Inc's 13F filing for Q2 2026, filed 12 Aug 2026.